Abstract:The oral bioavailability of poorly water-soluble active pharmaceutical ingredient (API) is often inadequate for the desired therapeutic effect. Micro-environmental pH-modifying solid dispersion (micro pHm SD) is an effective method for enhancing the dissolution of pH-dependent soluble APIs. However, erratic bioavailability of these drugs was often found when the micro pHm SD of the drugs was orally administrated and passed through the gastrointestinal tract. Because the added alkalizer in micro pHm SD could be neutralized by the acid in the stomach, as a result not enough alkalizer is left to form alkaline micro-environment around the drug in the intestine, leading to poor dissolution and bioavailability of API. Enteric polymers are applicable materials for site-specific drug delivery that are insoluble in gastric tract but soluble in the intestine targeted for drug release. In this study, a poorly water-soluble model drug, toltrazuril (TOL), was prepared as enteric micro pHm SD with enteric, hydrophilic polymers and alkalizer. The surface of enteric micro pHm SD tablets staining and alkalizer protection test in the acid dissolution medium qualitatively and quantitatively confirmed the protective effects of the enteric polymer on the alkalizer. Dissolution studies revealed that the drug release from the enteric micro pHm SDs was improved significantly compared with micro pHm SD with no enteric polymer. The pH-dependent solubility of enteric polymer had effects on the dissolution of APIs from the SDs in neutral medium. Enteric micro pHm SDs with higher proportion of enteric polymer showed higher Cmax and dissolution rate of TOL. The physicochemical characterization and the molecular interaction between drug and matrix were analyzed by electron microscopy (SEM), differential scanning calorimetry (DSC), and fourier transform infrared spectroscopy (FTIR), finding that the formation of hydrogen bonds between TOL and matrix was helpful to promote dissolution of TOL. Ca(OH)2-TOL-PVPk30-HPMCAS 8: 8: 18: 6 was determined as the most optimal enteric micro pHm SD, which significantly improved the bioavailability of TOL and its active metabolism (TOLSO, TOLSO2) in pharmacokinetic study and could effectively reduce the irritation of the gastrointestinal mucosa caused by the alkalizer Ca(OH)2 when the SD was orally administrated to rabbits. The present study demonstrates that formulating APIs with poor water solubility as enteric micro pHm SD is an effective method for protecting the alkalizer in SD and improving the dissolution of APIs and the bioavailability following oral administration.

A comparative study of the effect of different alkaline stabilizers on physicochemical properties of lansoprazole in formulation

Influences of Sodium Carbonate on Physicochemical Properties of Lansoprazole in Designed Multiple Coating Pellets

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Eudragit L/HPMCAS Blend Enteric-Coated Lansoprazole Pellets: Enhanced Drug Stability and Oral Bioavailability

Enteric-coating film effect on the delayed drug release of pantoprazole gastro-resistant generic tablets

Physical Characterization of Lansoprazole/Pvp Solid Dispersion Prepared by Fluid-Bed Coating Technique

Design, formulation, and evaluation of delayed release oral dosage form of proton pump inhibitor

Enhanced Dissolution and Stability of Lansoprazole by Cyclodextrin Inclusion Complexation: Preparation, Characterization, and Molecular Modeling

Study of the influence of alkalizing components on matrix pellets prepared by extrusion/spheronization

Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets

Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion

Could the Change of Excipient Content Improve the Stability of Gastroresistant Omeprazole Pellets?

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole

Preparation of Ketoprofen/Lansoprazole Matrix Sustained-Release Pellets and In Vitro Evaluation

Study in the Stabilization of Proteins Encapsulated in PLGA Delivery System: Effects of Additives on Protein Encapsulation, Release, and Stability

Co-amorphous Solid Dispersion Systems of Lacidipine-Spironolactone with Improved Dissolution Rate and Enhanced Physical Stability

Impact of Surface Properties of Core Material on the Stability of Hot Melt-Coated Multiparticulate Systems

Novel Application Method of Talcum Powder to Prevent Sticking Tendency and Modify Release of Esomeprazole Magnesium Enteric-Coated Pellets

Preparation of esomeprazole magnesium enteric-coated pellets by extrusion spheronization

Preparation and Release of Potassium Citrate Sustained-Release Tablets

Enhanced Oral Bioavailability of Novel Mucoadhesive Pellets Containing Valsartan Prepared by a Dry Powder-Coating Technique.